P2-pyrimidinergic receptors and their ligands.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Current pharmaceutical design

• Publication date

  2002-11-30

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.2174/1381612023392937PMID 12369950
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fast, efficient capillary electrophoresis method for measuring nucleotide degradation and metabolism.

  2002cited by this paper
• P2Y(2) receptor agonists: a new class of medication targeted at improved mucociliary clearance.

  2002cited by this paper
• Structure-activity relationships of suramin and pyridoxal-5'-phosphate derivatives as P2 receptor antagonists.

  2002cited by this paper
• Methanocarba modification of uracil and adenine nucleotides: high potency of Northern ring conformation at P2Y1, P2Y2, P2Y4, and P2Y11 but not P2Y6 receptors.

  2002cited by this paper
• Extracellular nucleotides inhibit growth of human oesophageal cancer cells via P2Y2-receptors

  2002cited by this paper
• Identification of a Novel Human ADP Receptor Coupled to Gi *

  2001cited by this paper
• Peptide-nucleic acids (PNAs): a tool for the development of gene expression modifiers.

  2001cited by this paper
• Activity of diadenosine polyphosphates at P2Y receptors stably expressed in 1321N1 cells.

  2001cited by this paper
• Synthesis and P2Y receptor activity of a series of uridine dinucleoside 5'-polyphosphates.

  2001cited by this paper
• International union of pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits.

  2001cited by this paper
• Ocular Safety of INS365 Ophthalmic Solution: A P2Y2 Agonist In Healthy Subjects

  2001cited by this paper
• Cloning and functional characterization of two murine uridine nucleotide receptors reveal a potential target for correcting ion transport deficiency in cystic fibrosis gallbladder.

  2001cited by this paper
• Safety of aerosolized INS 365 in patients with mild to moderate cystic fibrosis: Results of a phase I multi‐center study

  2001cited by this paper
• P2Y2 nucleotide receptor signaling in human monocytic cells: Activation, desensitization and coupling to mitogen‐activated protein kinases

  2001cited by this paper
• Intercalators as anticancer drugs.

  2001cited by this paper
• Heteromeric association creates a P2Y-like adenosine receptor

  2001cited by this paper
• P2Y6 Nucleotide Receptor Mediates Monocyte Interleukin-8 Production in Response to UDP or Lipopolysaccharide*

  2001cited by this paper
• Molecular cloning and characterization of the mouse P2Y4 nucleotide receptor.

  2001cited by this paper
• Cloning, pharmacology, and tissue distribution of G-protein-coupled receptor GPR105 (KIAA0001) rodent orthologs.

  2001cited by this paper
• Improvement of corneal barrier function by the P2Y(2) agonist INS365 in a rat dry eye model.

  2001cited by this paper
• SH3 domains: complexity in moderation.

  2001cited by this paper
• Differential effects of UTP, ATP, and adenosine on ciliary activity of human nasal epithelial cells.

  2001cited by this paper
• An elusive receptor is finally caught: P2Y(12'), an important drug target in platelets.

  2001cited by this paper
• Effect of aerosolized uridine 5'-triphosphate on mucociliary clearance in mild chronic bronchitis.

  2001cited by this paper
• Identification of the P2Y(12) receptor: a novel member of the P2Y family of receptors activated by extracellular nucleotides.

  2001cited by this paper
• Role of cytokines and cytokine therapy in wound healing and fibrotic diseases.

  2001cited by this paper
• An arginine/glutamine difference at the juxtaposition of transmembrane domain 6 and the third extracellular loop contributes to the markedly different nucleotide selectivities of human and canine P2Y11 receptors.

  2001cited by this paper
• P2Y(2) receptor of MDCK cells: cloning, expression, and cell-specific signaling.

  2000cited by this paper
• Molecular pharmacology of P2Y-receptors

  2000cited by this paper
• Extracellular metabolism of ATP and other nucleotides

  2000cited by this paper
• ATP as a presynaptic modulator.

  2000cited by this paper
• A molecularly identified P2Y receptor simultaneously activates phospholipase C and inhibits adenylyl cyclase and is nonselectively activated by all nucleoside triphosphates.

  2000cited by this paper
• P2Y(1), P2Y(2), P2Y(4), and P2Y(6) receptors are coupled to Rho and Rho kinase activation in vascular myocytes.

  2000cited by this paper
• Mechanisms of agonist-dependent and -independent desensitization of a recombinant P2Y2 nucleotide receptor

  2000cited by this paper
• ATP, an agonist at the rat P2Y(4) receptor, is an antagonist at the human P2Y(4) receptor.

  2000cited by this paper
• P2Y receptors contribute to ATP-induced increases in intracellular calcium in differentiated but not undifferentiated PC12 cells.

  2000cited by this paper
• Characterization of contractile P2 receptors in human coronary arteries by use of the stable pyrimidines uridine 5'-O-thiodiphosphate and uridine 5'-O-3-thiotriphosphate.

  2000cited by this paper
• A G Protein-coupled Receptor for UDP-glucose*

  2000cited by this paper
• Inhibitory effects of some purinergic agents on ecto-ATPase activity and pattern of stepwise ATP hydrolysis in rat liver plasma membranes.

  2000cited by this paper
• Effect of shear stress on the release of soluble ecto‐enzymes ATPase and 5′‐nucleotidase along with endogenous ATP from vascular endothelial cells

  2000cited by this paper
• The Synthesis of Cyclonucleotides with Fixed Glycosidic Bond Linkages as Putative Agonists for P2-Purinergic Receptors

  2000cited by this paper
• Role of the extracellular loops of G protein-coupled receptors in ligand recognition: a molecular modeling study of the human P2Y1 receptor.

  1999cited by this paper
• Human P2Y2 receptor polymorphism: identification and pharmacological characterization of two allelic variants

  1999cited by this paper
• Molecular pharmacology of the CFTR Cl- channel.

  1999cited by this paper
• Neuroprotective effects of modulators of P2 receptors in primary culture of CNS neurones.

  1999cited by this paper
• Effect of Loss of P2Y2 Receptor Gene Expression on Nucleotide Regulation of Murine Epithelial Cl−Transport*

  1999cited by this paper
• Aerosolization of P2Y(2)-receptor agonists enhances mucociliary clearance in sheep.

  1999cited by this paper
• Receptors for purines and pyrimidines.

  1998cited by this paper
• Evidence that the p2y3 receptor is the avian homologue of the mammalian P2Y6 receptor.

  1998cited by this paper
• Molecular cloning and characterization of rat P2Y4 nucleotide receptor

  1998cited by this paper
• Molecular Cloning and Characterization of the Rat P2Y4 Receptor

  1998cited by this paper
• Metabotropic receptors for ATP and UTP: exploring the correspondence between native and recombinant nucleotide receptors.

  1998cited by this paper
• Human P2Y1 receptor: molecular modeling and site-directed mutagenesis as tools to identify agonist and antagonist recognition sites.

  1998cited by this paper
• P2X1 and P2X3 receptors form stable trimers: a novel structural motif of ligand‐gated ion channels

  1998cited by this paper
• Purification of chemically synthesised dinucleoside(5',5') polyphosphates by displacement chromatography.

  1998cited by this paper
• Expression of the P2Y6 purinergic receptor in human T cells infiltrating inflammatory bowel disease.

  1998cited by this paper
• Differential characterization of binding sites for adenine and uridine nucleotides in membranes from rat lung as possible tools for studying P2 receptors in lung.

  1998cited by this paper
• A mutational analysis of residues essential for ligand recognition at the human P2Y1 receptor.

  1997cited by this paper
• Cloning of a human heptahelical receptor closely related to the P2Y5 receptor.

  1997cited by this paper
• Release, metabolism and interconversion of adenine and uridine nucleotides: implications for G protein-coupled P2 receptor agonist selectivity.

  1997cited by this paper
• Transient up-regulation of P2Y2 nucleotide receptor mRNA expression is an immediate early gene response in activated thymocytes.

  1997cited by this paper
• Slow desensitization of the human P2Y6 receptor.

  1997cited by this paper
• Receptors responsive to extracellular pyrimidine nucleotides.

  1997cited by this paper
• Early Expression of a Novel Nucleotide Receptor in the Neural Plate of Xenopus Embryos*

  1997cited by this paper
• Uridine Nucleotide Receptors and Their Ligands: Structural, Physiological, and Pathophysiological Aspects, with Special Emphasis on the Nervous System

  1997cited by this paper
• Different sensitivities to pH of ATP-induced currents at four cloned P2X receptors.

  1997cited by this paper
• HEK293 human embryonic kidney cells endogenously express the P2Y1 and P2Y2 receptors.

  1997cited by this paper
• Nucleotide receptors.

  1997cited by this paper
• Pharmacological characterization of the human P2Y4 receptor.

  1996cited by this paper
• PPADS and suramin as antagonists at cloned P2Y‐ and P2U‐purinoceptors

  1996cited by this paper
• Cloning of the rat P2u receptor and its potential role in coronary vasodilation.

  1996cited by this paper
• Desensitization of P2U receptor in neuronal cell line. Different control by the agonists ATP and UTP, as demonstrated by single-cell Ca2+ responses.

  1996cited by this paper
• Cloned and transfected P2Y4 receptors: characterization of a suramin and PPADS‐insensitive response to UTP

  1996cited by this paper
• Cloning, functional expression and tissue distribution of the human P2Y6 receptor.

  1996cited by this paper
• Uridine nucleotide selectivity of three phospholipase C-activating P2 receptors: identification of a UDP-selective, a UTP-selective, and an ATP- and UTP-specific receptor.

  1996cited by this paper
• Enzymatic synthesis of UTP gamma S, a potent hydrolysis resistant agonist of P2U-purinoceptors.

  1996cited by this paper
• Cloning, Expression, and Chromosomal Localization of the Human Uridine Nucleotide Receptor Gene (*)

  1995cited by this paper
• Pharmacological selectivity of the cloned human P2U‐purinoceptor: potent activation by diadenosine tetraphosphate

  1995cited by this paper
• Cloning and Functional Expression of a Human Uridine Nucleotide Receptor (*)

  1995cited by this paper
• Molecular Cloning and Functional Analysis of a Novel P2 Nucleotide Receptor (*)

  1995cited by this paper
• Site-directed Mutagenesis of P2U Purinoceptors

  1995cited by this paper
• Identification of a uridine nucleotide-selective G-protein-linked receptor that activates phospholipase C.

  1994cited by this paper
• Cloning and expression of a human P2U nucleotide receptor, a target for cystic fibrosis pharmacotherapy.

  1994cited by this paper
• New structural motif for ligand-gated ion channels defined by an ionotropic ATP receptor

  1994cited by this paper
• Signal transduction pathways coupled to a P2U receptor in neuroblastoma x glioma (NG108-15) cells.

  1993cited by this paper
• Functional expression and photoaffinity labeling of a cloned P2U purinergic receptor.

  1993cited by this paper
• Expression cloning of an ATP receptor from mouse neuroblastoma cells.

  1993cited by this paper
• Rat Brain Synaptosomal ATP:AMP‐Phosphotransferase Activity

  1989cited by this paper

• Transcriptomic profiling of dorsal root ganglia in atopic and healthy dogs: A comparative RNA sequencing study with implications in cutaneous itch research

  2025cites this paper
• The Use of Biologics for Targeting GPCRs in Metastatic Cancers

  2025cites this paper
• Pharmacological characterization of P2Y receptor subtypes – an update

  2023cites this paper
• Purinergic receptors modulators: An emerging pharmacological tool for disease management

  2022cites this paper
• Pharmacology of P2Y receptors.

  2019cites this paper
• Allergic sensitization increases the amount of extracellular ATP hydrolyzed by guinea pig leukocytes

  2019cites this paper
• Molecular dynamic simulations reveal structural insights into substrate and inhibitor binding modes and functionality of Ecto-Nucleoside Triphosphate Diphosphohydrolases

  2018cites this paper
• Tools and drugs for uracil nucleotide‐activated P2Y receptors

  2018cites this paper
• P 2 Y 6 purinergic receptor regulates steroid synthesis and proliferation of ovarian luteal cells

  2017cites this paper
• Structure, Pharmacology and Roles in Physiology of the P2Y12 Receptor.

  2017cites this paper
• Thymidine 5'-O-monophosphorothioate induces HeLa cell migration by activation of the P2Y6 receptor

  2016cites this paper
• Purinergic signalling-evoked intracellular Ca(2+) concentration changes in the regulation of chondrogenesis and skeletal muscle formation.

  2016cites this paper
• Pharmacology and structure of P2Y receptors.

  2016cites this paper
• Akt signaling and coordinated changes in the distribution and expression of akt-regulating phosphatases

  2014cites this paper
• Plasma ATP is Required for Neutrophil Activation in a Mouse Sepsis Model

  2014cites this paper
• Synthesis, biological activity and molecular modelling studies of tricyclic alkylimidazo-, pyrimido- and diazepinopurinediones

  2013cites this paper
• Convergent Synthesis of the Potent P2Y Receptor Antagonist MG 50-3-1 Based on a Regioselective Ullmann Coupling Reaction

  2012cites this paper
• Purinergic Receptors Influence the Differentiation of Human Mesenchymal Stem Cells

  2012cites this paper
• NTPDase1 Controls IL-8 Production by Human Neutrophils

  2011cites this paper
• Molecular pharmacology, physiology, and structure of the P2Y receptors.

  2011cites this paper
• Synthesis of alkyl- and aryl-amino-substituted anthraquinone derivatives by microwave-assisted copper(0)-catalyzed Ullmann coupling reactions

  2010cites this paper
• Development of potent and selective inhibitors of ecto-5'-nucleotidase based on an anthraquinone scaffold.

  2010cites this paper
• The P2 receptor antagonist PPADS abrogates LPS-induced neutrophil migration in the murine air pouch via inhibition of MIP-2 and KC production.

  2010cites this paper
• High-affinity, non-nucleotide-derived competitive antagonists of platelet P2Y12 receptors.

  2009cites this paper
• Statin-induced cellular effects mediated by the P2X7 receptor

  2009cites this paper
• Structure-activity relationships of adenine and deazaadenine derivatives as ligands for adenine receptors, a new purinergic receptor family.

  2009cites this paper
• Predictive 3D‐Quantitative Structure‐Activity Relationship for A1 and A2A Adenosine Receptor Ligands

  2009cites this paper
• Synthesis of uracil nucleotide analogs with a modified, acyclic ribose moiety as P2Y(2) receptor antagonists.

  2009cites this paper
• Purines as Transmitter Molecules: Electrophysiological Studies on Purinergic Signalling in Different Cell Systems

  2009cites this paper
• Development of selective agonists and antagonists of P2Y receptors

  2008cites this paper
• Extracellular ATP Increases L-Carnitine Transport and Content in C2C12 Cells

  2008cites this paper
• Combinatorial synthesis of anilinoanthraquinone derivatives and evaluation as non-nucleotide-derived P2Y2 receptor antagonists.

  2008cites this paper
• Development of potent and selective antagonists at P2Y11 receptors: Symmetrical and asymmetrical derivatives of NF340

  2008cites this paper
• A living cell-based biosensor utilizing G-protein coupled receptors: principles and detection methods.

  2007cites this paper
• Rapid and efficient microwave-assisted copper(0)-catalyzed ullmann coupling reaction: general access to anilinoanthraquinone derivatives.

  2007cites this paper
• New iantherans from the marine sponge Ianthella quadrangulata: novel agonists of the P2Y(11) receptor.

  2007cites this paper
• Catalyst-free microwave-assisted amination of 2-chloro-5-nitrobenzoic acid.

  2007cites this paper
• Role of aromatic and charged ectodomain residues in the P2X4 receptor functions

  2007cites this paper
• Differential effects of cyclic and constant stress on ATP release and mucociliary transport by human airway epithelia

  2007cites this paper
• Polyoxometalates--a new class of potent ecto-nucleoside triphosphate diphosphohydrolase (NTPDase) inhibitors.

  2006cites this paper
• Pharmacological profiles of cloned mammalian P2Y-receptor subtypes.

  2006cites this paper
• Effect of Extracellular ATP on the Human Leukaemic Cell Line K562 and its Multidrug Counterpart

  2006cites this paper
• Potent adenosine A1 and A2A receptors antagonists: recent developments.

  2006cites this paper
• Pharmacological profiles of cloned mammalian P2Y-receptor subtypes

  2006cites this paper
• ATP Release Mechanisms

  2006cites this paper
• Activation of human eosinophils via P2 receptors: novel findings and future perspectives

  2006cites this paper
• Integration of P2Y receptor-activated signal transduction pathways in G protein-dependent signalling networks

  2006cites this paper
• Structure activity and molecular modeling analyses of ribose- and base-modified uridine 5'-triphosphate analogues at the human P2Y2 and P2Y4 receptors.

  2006cites this paper
• Nucleoside triphosphate diphosphohydrolase‐2 is the ecto‐ATPase of type I cells in taste buds

  2006cites this paper
• International Union of Pharmacology LVIII: Update on the P2Y G Protein-Coupled Nucleotide Receptors: From Molecular Mechanisms and Pathophysiology to Therapy

  2006cites this paper
• Synthesis and preliminary evaluation of [3H]PSB-0413, a selective antagonist radioligand for platelet P2Y12 receptors.

  2005cites this paper
• Comparative hydrolysis of P2 receptor agonists by NTPDases 1, 2, 3 and 8

  2005cites this paper
• Cloning and characterization of mouse nucleoside triphosphate diphosphohydrolase-8.

  2004cites this paper
• Structure-activity relationships of analogues of NF449 confirm NF449 as the most potent and selective known P2X1 receptor antagonist.

  2004cites this paper
• The role of glia cells in purine receptor-induced neuroprotection

  2004influential citation
• cAMP Potentiates ATP-evoked Calcium Signaling in Human Parotid Acinar Cells*

  2004cites this paper
• Subtype specific internalization of P2Y1 and P2Y2 receptors induced by novel adenosine 5′‐O‐(1‐boranotriphosphate) derivatives

  2004cites this paper
• Preparation, properties, reactions, and adenosine receptor affinities of sulfophenylxanthine nitrophenyl esters: toward the development of sulfonic acid prodrugs with peroral bioavailability.

  2004cites this paper
• Adenosine-induced neuroprotection: involvement of glia cells and cytokines

  2004cites this paper
• Molecular recognition at purine and pyrimidine nucleotide (P2) receptors.

  2004cites this paper
• Flavonoids — novel lead compounds for the development of P2Y2 receptor antagonists

  2003influential citation
• Role of Nucleotide P2 Receptors in Calcium Signaling and Prolactin Release in Pituitary Lactotrophs*

  2003cites this paper
• Human Neutrophils NTPDase1 Controls IL-8 Production by

  year unknowncites this paper